Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm
In 1991, we reported 18 persons with a clinical-pathologic entity and termed atypical myeloproliferative disorder because they did not meet the contemporary diagnostic criteria for a myeloproliferative neoplasm. We sought to gain further knowledge on this disease entity. This retrospective cohort st...
Uloženo v:
| Vydáno v: | Acta haematologica Ročník 145; číslo 1; s. 30 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
01.01.2022
|
| Témata: | |
| ISSN: | 1421-9662, 1421-9662 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | In 1991, we reported 18 persons with a clinical-pathologic entity and termed atypical myeloproliferative disorder because they did not meet the contemporary diagnostic criteria for a myeloproliferative neoplasm. We sought to gain further knowledge on this disease entity.
This retrospective cohort study included consecutive subjects registered in the database of the Center for the Study of Myelofibrosis in Pavia, Italy, from 1998 to 2020 (June), and diagnosed with atypical myeloproliferative disorder according to our adjudicated criteria. We studied clinical, histological, cytogenetic, and molecular covariates and risks of thrombosis, disease progression, and death. Data were compared with those of concurrent subjects with prefibrotic myelofibrosis.
Fifteen new subjects with atypical myeloproliferative disorder were identified. Seven were male. Median age was 50 years (IQR, 41-54 years). Thirteen were diagnosed with a synchronous symptomatic or incidentally detected thrombotic event. The bone marrow showed megakaryocyte hyperplasia with dysplasia. JAK2V617F was present in 10 subjects and CALR mutation in one. No other somatic mutations were identified in next generation sequencing. After a median follow-up of 101 months (IQR, 40-160 months), no subject had disease progression or blast transformation. Incidence of post-diagnosis or recurrent thrombosis was 3.9 events (95% confidence interval, 3.5-4.0) and 5.0 events (4.6-5.6) per 100 person-years. Features of subjects with atypical myeloproliferative disorder differed markedly from those of 546 subjects with prefibrotic myelofibrosis.
Our data indicate that these 15 persons have a distinct myeloproliferative neoplasm. We propose naming this new disorder clonal megakaryocyte dysplasia with normal blood values. |
|---|---|
| AbstractList | In 1991, we reported 18 persons with a clinical-pathologic entity and termed atypical myeloproliferative disorder because they did not meet the contemporary diagnostic criteria for a myeloproliferative neoplasm. We sought to gain further knowledge on this disease entity.
This retrospective cohort study included consecutive subjects registered in the database of the Center for the Study of Myelofibrosis in Pavia, Italy, from 1998 to 2020 (June), and diagnosed with atypical myeloproliferative disorder according to our adjudicated criteria. We studied clinical, histological, cytogenetic, and molecular covariates and risks of thrombosis, disease progression, and death. Data were compared with those of concurrent subjects with prefibrotic myelofibrosis.
Fifteen new subjects with atypical myeloproliferative disorder were identified. Seven were male. Median age was 50 years (IQR, 41-54 years). Thirteen were diagnosed with a synchronous symptomatic or incidentally detected thrombotic event. The bone marrow showed megakaryocyte hyperplasia with dysplasia. JAK2V617F was present in 10 subjects and CALR mutation in one. No other somatic mutations were identified in next generation sequencing. After a median follow-up of 101 months (IQR, 40-160 months), no subject had disease progression or blast transformation. Incidence of post-diagnosis or recurrent thrombosis was 3.9 events (95% confidence interval, 3.5-4.0) and 5.0 events (4.6-5.6) per 100 person-years. Features of subjects with atypical myeloproliferative disorder differed markedly from those of 546 subjects with prefibrotic myelofibrosis.
Our data indicate that these 15 persons have a distinct myeloproliferative neoplasm. We propose naming this new disorder clonal megakaryocyte dysplasia with normal blood values. In 1991, we reported 18 persons with a clinical-pathologic entity and termed atypical myeloproliferative disorder because they did not meet the contemporary diagnostic criteria for a myeloproliferative neoplasm. We sought to gain further knowledge on this disease entity.INTRODUCTIONIn 1991, we reported 18 persons with a clinical-pathologic entity and termed atypical myeloproliferative disorder because they did not meet the contemporary diagnostic criteria for a myeloproliferative neoplasm. We sought to gain further knowledge on this disease entity.This retrospective cohort study included consecutive subjects registered in the database of the Center for the Study of Myelofibrosis in Pavia, Italy, from 1998 to 2020 (June), and diagnosed with atypical myeloproliferative disorder according to our adjudicated criteria. We studied clinical, histological, cytogenetic, and molecular covariates and risks of thrombosis, disease progression, and death. Data were compared with those of concurrent subjects with prefibrotic myelofibrosis.METHODSThis retrospective cohort study included consecutive subjects registered in the database of the Center for the Study of Myelofibrosis in Pavia, Italy, from 1998 to 2020 (June), and diagnosed with atypical myeloproliferative disorder according to our adjudicated criteria. We studied clinical, histological, cytogenetic, and molecular covariates and risks of thrombosis, disease progression, and death. Data were compared with those of concurrent subjects with prefibrotic myelofibrosis.Fifteen new subjects with atypical myeloproliferative disorder were identified. Seven were male. Median age was 50 years (IQR, 41-54 years). Thirteen were diagnosed with a synchronous symptomatic or incidentally detected thrombotic event. The bone marrow showed megakaryocyte hyperplasia with dysplasia. JAK2V617F was present in 10 subjects and CALR mutation in one. No other somatic mutations were identified in next generation sequencing. After a median follow-up of 101 months (IQR, 40-160 months), no subject had disease progression or blast transformation. Incidence of post-diagnosis or recurrent thrombosis was 3.9 events (95% confidence interval, 3.5-4.0) and 5.0 events (4.6-5.6) per 100 person-years. Features of subjects with atypical myeloproliferative disorder differed markedly from those of 546 subjects with prefibrotic myelofibrosis.RESULTSFifteen new subjects with atypical myeloproliferative disorder were identified. Seven were male. Median age was 50 years (IQR, 41-54 years). Thirteen were diagnosed with a synchronous symptomatic or incidentally detected thrombotic event. The bone marrow showed megakaryocyte hyperplasia with dysplasia. JAK2V617F was present in 10 subjects and CALR mutation in one. No other somatic mutations were identified in next generation sequencing. After a median follow-up of 101 months (IQR, 40-160 months), no subject had disease progression or blast transformation. Incidence of post-diagnosis or recurrent thrombosis was 3.9 events (95% confidence interval, 3.5-4.0) and 5.0 events (4.6-5.6) per 100 person-years. Features of subjects with atypical myeloproliferative disorder differed markedly from those of 546 subjects with prefibrotic myelofibrosis.Our data indicate that these 15 persons have a distinct myeloproliferative neoplasm. We propose naming this new disorder clonal megakaryocyte dysplasia with normal blood values.CONCLUSIONOur data indicate that these 15 persons have a distinct myeloproliferative neoplasm. We propose naming this new disorder clonal megakaryocyte dysplasia with normal blood values. |
| Author | Abbà, Carlotta Primignani, Massimo Campanelli, Rita Gregato, Giuliana Barosi, Giovanni Gale, Robert Peter Bertolini, Francesco Magrini, Umberto Massa, Margherita Catarsi, Paolo Lodigiani, Corrado Carolei, Adriana Rosti, Vittorio Villani, Laura |
| Author_xml | – sequence: 1 givenname: Giovanni surname: Barosi fullname: Barosi, Giovanni organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 2 givenname: Vittorio surname: Rosti fullname: Rosti, Vittorio organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 3 givenname: Margherita surname: Massa fullname: Massa, Margherita organization: Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy – sequence: 4 givenname: Rita surname: Campanelli fullname: Campanelli, Rita organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 5 givenname: Laura surname: Villani fullname: Villani, Laura organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 6 givenname: Paolo surname: Catarsi fullname: Catarsi, Paolo organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 7 givenname: Adriana surname: Carolei fullname: Carolei, Adriana organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 8 givenname: Carlotta surname: Abbà fullname: Abbà, Carlotta organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 9 givenname: Corrado surname: Lodigiani fullname: Lodigiani, Corrado organization: IRCCS Humanitas Clinical and Research Center, Rozzano, Italy – sequence: 10 givenname: Massimo surname: Primignani fullname: Primignani, Massimo organization: Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, CRC "A. M. and A. Migliavacca" Center for Liver Disease, Milan, Italy – sequence: 11 givenname: Giuliana surname: Gregato fullname: Gregato, Giuliana organization: Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy – sequence: 12 givenname: Francesco surname: Bertolini fullname: Bertolini, Francesco organization: Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy – sequence: 13 givenname: Umberto surname: Magrini fullname: Magrini, Umberto organization: Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy – sequence: 14 givenname: Robert Peter surname: Gale fullname: Gale, Robert Peter organization: Department of Immunology and Inflammation, Center for Haematology Research, Imperial College London, London, United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34280924$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkElPwzAUhC1URBc48AeQj1wCz0sWH6FlqdSWC3CNXhIbDE5c4hSUf08QReI0c_g0mpkpGTW-0YScMrhgLFaXABCzlEN6QCZMchapJOGjf35MpiG8ATCeCnVExkLyDBSXE4Jz5xt0dK1f8B3b3pd9p-miD1uHwSL9st0r3fi2Hphr531Fn9HtdKDLQJEubOhsU3Z03Wvnt6131ugWO_up6Ub7n4z6mBwadEGf7HVGnm5vHuf30erhbjm_WkWlELKLiooZkKwAAVImpmQApdGqSCBDiDVPwbBEyRS5GcYWIuUVIjMxKs2EqhSfkfPf3KHGx9Cwy2sbSu0cNtrvQs7jWMScZ0k2oGd7dFfUusq3ra2H7fnfLfwbsJpk_Q |
| CitedBy_id | crossref_primary_10_1002_jha2_708 crossref_primary_10_1182_bloodadvances_2023012110 crossref_primary_10_1038_s41375_023_01861_9 crossref_primary_10_1182_bloodadvances_2023012190 crossref_primary_10_1182_blood_2023023579 crossref_primary_10_1002_ajh_26896 |
| ContentType | Journal Article |
| Copyright | 2021 S. Karger AG, Basel. |
| Copyright_xml | – notice: 2021 S. Karger AG, Basel. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1159/000517207 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1421-9662 |
| ExternalDocumentID | 34280924 |
| Genre | Clinical Trial Journal Article |
| GroupedDBID | --- .55 .GJ 0R~ 0~5 0~B 23M 30W 328 34G 36B 39C 3O- 3O. 4.4 53G 5GY 5RE 8UI AAYIC ABBTS ABJNI ABPAZ ABWCG ACGFS ACPSR ACQXL ADAGL ADBBV AENEX AEYAO AFDXO AFFNX AFJJK AFSIO AHFRZ AI. ALDHI ALMA_UNASSIGNED_HOLDINGS AZPMC C45 CAG CGR COF CS3 CUY CVF CYUIP E0A EBS ECM EIF EJD EMB EMOBN F5P FB. HZ~ IY7 KUZGX L7B N9A NPM O1H O9- OVD P2P RIG RKO RXVBD SV3 TEORI UDS UJ6 VH1 X7M ZGI ZXP 7X8 |
| ID | FETCH-LOGICAL-c334t-bd1f041b030446fc100cfe9b608a05e270f16947a2f051b372daa1f5a9e139d92 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000675438600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1421-9662 |
| IngestDate | Fri Jul 11 09:36:46 EDT 2025 Wed Feb 19 02:27:38 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Prefibrotic myelofibrosis Megakaryocyte dysplasia Atypical myeloproliferative disorder Myelofibrosis Myeloproliferative neoplasm |
| Language | English |
| License | 2021 S. Karger AG, Basel. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c334t-bd1f041b030446fc100cfe9b608a05e270f16947a2f051b372daa1f5a9e139d92 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| PMID | 34280924 |
| PQID | 2553522868 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2553522868 pubmed_primary_34280924 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Acta haematologica |
| PublicationTitleAlternate | Acta Haematol |
| PublicationYear | 2022 |
| SSID | ssj0012739 |
| Score | 2.337806 |
| Snippet | In 1991, we reported 18 persons with a clinical-pathologic entity and termed atypical myeloproliferative disorder because they did not meet the contemporary... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 30 |
| SubjectTerms | Adult Amino Acid Substitution Bone Marrow - metabolism Bone Marrow - pathology Calreticulin - genetics Calreticulin - metabolism Female Hematologic Neoplasms - blood Hematologic Neoplasms - genetics Hematologic Neoplasms - pathology Humans Janus Kinase 2 - genetics Janus Kinase 2 - metabolism Male Megakaryocytes - metabolism Megakaryocytes - pathology Middle Aged Mutation, Missense Myeloproliferative Disorders - blood Myeloproliferative Disorders - genetics Myeloproliferative Disorders - pathology Retrospective Studies Thrombosis |
| Title | Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34280924 https://www.proquest.com/docview/2553522868 |
| Volume | 145 |
| WOSCitedRecordID | wos000675438600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA6-EC--6vtBBPG2mH00uzmJr6KHLj2o9FZm8xCxbqtbhf33zqQrPQmCl70FwiQ7830zX2YYO820U0hyTBAaQIJipA6ULHQQUjuoWCsdg_HDJtI8z_p91WsSblUjq_zxid5Rm5GmHPk5Ql_CCpnMLsbvAU2NoupqM0Jjni3GCGVI0pX2Z1UEDM3Kvy4iGYKUUdNZCCO4n2WHsVukvyNLH2E6a__d2zpbbbAlv5xehg02Z8tN1roskVe_1fyMe7WnT6NvsuVuU1RvMbgeEhznXfsMr_BRj3Q9sfymrsb-iSWnVC3PCdsO-RXp3PkTDHF3_L7iwG_ISZR6wrs1qY9oCJCz03biPCd5OlRvW-yxc_twfRc0kxcCHcfJJChM6EQSFlQ3TaTToRDaWVVIkYFo2ygVLpQqSSFyaMYiTiMDELo2KIvHYFS0zRbKUWl3GRcuiRPkgEbIIrEQFm2TFtpAYjVYJIN77OTHpgO82VSugNKOPqvBzKp7bGd6MIPxtAXHIEbWJJA67v9h9QFbiejNgs-bHLJFh_-1PWJL-mvyUn0c-yuD37zX_QY5p8xh |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clonal+Megakaryocyte+Dysplasia+with+Normal+Blood+Values+Is+a+Distinct+Myeloproliferative+Neoplasm&rft.jtitle=Acta+haematologica&rft.au=Barosi%2C+Giovanni&rft.au=Rosti%2C+Vittorio&rft.au=Massa%2C+Margherita&rft.au=Campanelli%2C+Rita&rft.date=2022-01-01&rft.issn=1421-9662&rft.eissn=1421-9662&rft.volume=145&rft.issue=1&rft.spage=30&rft_id=info:doi/10.1159%2F000517207&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1421-9662&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1421-9662&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1421-9662&client=summon |